An Expert Group on Cannabis set up by the Advisory Council on the Misuse of Drugs, made up of medical and scientific authorities and chaired by the pharmacologist J. D. P. Graham, downplayed the risks of cannabis. Attention turned to its possible benefits, especially for the side effects of cancer treatment; the synthetic cannabinoid nabilone was licensed two years later.[1]
Listed for context. No score change is recorded for United Kingdom here.
References
- Forces of Necessity: Lay Advocacy and the Remedicalization of Cannabis in the UK, 1973–2004Suzanne Taylor · In Cannabis: Global Histories, edited by Lucas Richert, James H. Mills · MIT Press · 2021 · pp. 343 · ISBN 9780262366137
Checked. The date and the event were compared with a source that was read.